To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.
Specifications
- Capacity:20 tests
- Description:RosetteSep™ HLA myeloid cell enrichment kit
- Cat. No.:MSPP-15272HLA
Specifications
About this item
Immunodensity isolation of untouched myeloid cells for lineage-specific chimerism analysis.
- Fast and easy-to-use
- Requires no special equipment or training
- Isolated cells are untouched
The RosetteSep™ HLA Myeloid Cell Enrichment Cocktail is designed to enrich myeloid (CD33+) cells from whole blood by negative selection for lineage-specific chimerism analysis. Unwanted cells are targeted for removal with Tetrameric Antibody Complexes recognizing CD3, CD8, CD19, CD56 and glycophorin A on red blood cells (RBCs). When centrifuged over a buoyant density medium such as RosetteSep™ DM-M (STMC15725), the unwanted cells pellet along with the RBCs. The purified myeloid cells are present as a highly enriched population at the interface between the plasma and the buoyant density medium. The desired cells are immediately ready for chimerism analysis or other downstream applications.
Please Note: In light of the new EU Regulation 2017/746 (IVDR) of the European Parliament and of the Council on in vitro diagnostic medical devices, which is expected to become effective in 2022, STEMCELL recently deregistered and removed the CE IVD claims associated with these products, and they are now labeled 'For Research Use Only'. Please note there have been no changes to the form, function and quality assurances associated with these products.